Treace Medical Concepts (TMCI) Competitors $7.44 -0.03 (-0.40%) Closing price 08/26/2025 04:00 PM EasternExtended Trading$7.44 +0.00 (+0.07%) As of 08/26/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TMCI vs. ENOV, CNMD, NVCR, SSII, CDRE, BLFS, ESTA, PLSE, MDXG, and INMDShould you be buying Treace Medical Concepts stock or one of its competitors? The main competitors of Treace Medical Concepts include Enovis (ENOV), CONMED (CNMD), NovoCure (NVCR), SS Innovations International (SSII), Cadre (CDRE), BioLife Solutions (BLFS), Establishment Labs (ESTA), Pulse Biosciences (PLSE), MiMedx Group (MDXG), and InMode (INMD). These companies are all part of the "medical equipment" industry. Treace Medical Concepts vs. Its Competitors Enovis CONMED NovoCure SS Innovations International Cadre BioLife Solutions Establishment Labs Pulse Biosciences MiMedx Group InMode Enovis (NYSE:ENOV) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, earnings, valuation, media sentiment, risk, analyst recommendations, profitability and institutional ownership. Do analysts recommend ENOV or TMCI? Enovis presently has a consensus price target of $51.00, suggesting a potential upside of 63.49%. Treace Medical Concepts has a consensus price target of $9.83, suggesting a potential upside of 32.17%. Given Enovis' stronger consensus rating and higher probable upside, analysts clearly believe Enovis is more favorable than Treace Medical Concepts.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Enovis 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00Treace Medical Concepts 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Which has more risk and volatility, ENOV or TMCI? Enovis has a beta of 1.7, suggesting that its stock price is 70% more volatile than the S&P 500. Comparatively, Treace Medical Concepts has a beta of 0.68, suggesting that its stock price is 32% less volatile than the S&P 500. Does the media refer more to ENOV or TMCI? In the previous week, Enovis had 11 more articles in the media than Treace Medical Concepts. MarketBeat recorded 13 mentions for Enovis and 2 mentions for Treace Medical Concepts. Enovis' average media sentiment score of 1.55 beat Treace Medical Concepts' score of 1.14 indicating that Enovis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Enovis 8 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Treace Medical Concepts 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is ENOV or TMCI more profitable? Treace Medical Concepts has a net margin of -23.01% compared to Enovis' net margin of -37.80%. Enovis' return on equity of 6.78% beat Treace Medical Concepts' return on equity.Company Net Margins Return on Equity Return on Assets Enovis-37.80% 6.78% 3.73% Treace Medical Concepts -23.01%-46.76%-23.35% Do insiders & institutionals hold more shares of ENOV or TMCI? 98.5% of Enovis shares are owned by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are owned by institutional investors. 2.7% of Enovis shares are owned by company insiders. Comparatively, 27.7% of Treace Medical Concepts shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has higher earnings & valuation, ENOV or TMCI? Treace Medical Concepts has lower revenue, but higher earnings than Enovis. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Enovis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnovis$2.11B0.85-$825.49M-$14.25-2.19Treace Medical Concepts$209.36M2.24-$55.74M-$0.79-9.42 SummaryEnovis beats Treace Medical Concepts on 11 of the 16 factors compared between the two stocks. Get Treace Medical Concepts News Delivered to You Automatically Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TMCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TMCI vs. The Competition Export to ExcelMetricTreace Medical ConceptsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$471.90M$6.92B$5.72B$9.73BDividend YieldN/A1.29%3.95%4.07%P/E Ratio-9.4227.0230.3026.09Price / Sales2.2470.79380.6987.72Price / CashN/A21.5337.7259.08Price / Book4.806.799.936.67Net Income-$55.74M$176.42M$3.27B$265.43M7 Day Performance4.20%3.48%3.66%3.36%1 Month Performance30.53%-2.06%3.83%0.39%1 Year Performance21.17%9.14%34.11%19.43% Treace Medical Concepts Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TMCITreace Medical Concepts2.4237 of 5 stars$7.44-0.4%$9.83+32.2%+18.5%$471.90M$209.36M-9.42250Positive NewsENOVEnovis4.5405 of 5 stars$29.51-0.1%$51.00+72.8%-31.7%$1.69B$2.11B-2.077,367Insider TradeCNMDCONMED3.9404 of 5 stars$53.35+0.4%$59.80+12.1%-24.6%$1.64B$1.31B15.113,900Positive NewsNVCRNovoCure4.1506 of 5 stars$12.09+3.1%$28.79+138.1%-34.8%$1.31B$605.22M-7.751,488SSIISS Innovations InternationalN/A$6.55-2.1%N/AN/A$1.30B$20.65M0.004Gap DownCDRECadre1.9239 of 5 stars$29.66+1.4%$31.50+6.2%-13.4%$1.19B$567.56M31.552,284Positive NewsBLFSBioLife Solutions2.614 of 5 stars$24.50+0.7%$31.29+27.7%-1.3%$1.17B$82.25M-204.15440News CoveragePositive NewsESTAEstablishment Labs1.8456 of 5 stars$38.25-0.2%$55.80+45.9%-9.4%$1.11B$166.02M-12.541,018Positive NewsPLSEPulse Biosciences3.9581 of 5 stars$15.68-3.0%$22.00+40.3%-17.6%$1.09B$700K-14.93140MDXGMiMedx Group3.3289 of 5 stars$7.19+1.1%$12.00+66.9%+6.5%$1.05B$348.88M34.24870Positive NewsINMDInMode2.1055 of 5 stars$14.31-0.3%$18.04+26.1%-7.5%$907.05M$394.82M5.79480News CoveragePositive News Related Companies and Tools Related Companies Enovis Alternatives CONMED Alternatives NovoCure Alternatives SS Innovations International Alternatives Cadre Alternatives BioLife Solutions Alternatives Establishment Labs Alternatives Pulse Biosciences Alternatives MiMedx Group Alternatives InMode Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TMCI) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Treace Medical Concepts, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Treace Medical Concepts With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access